Premium
iTeos Therapeutics Inc (ITOS)
NASDAQ
Hot Features
Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
| Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Return on Assets (%) | -146.515 | -91.288 | -23.129 | 34.902 | 11.789 | -15.836 |
| Return on Equity (%) | 375.838 | 113.48 | -30.234 | 48.976 | 15.895 | -18.189 |
| Return on Invested Capital (%) | -344.466 | -226.95 | -27.228 | 46.67 | 13.577 | -30.563 |
| Operating Margin (%) | N/A | N/A | N/A | 74.386 | 55.575 | -865.661 |
| Net Profit Margin (%) | N/A | N/A | N/A | 62.221 | 36.114 | -894.339 |
| Book Value Per Share | 80.93 | 60.969 | 9.222 | 15.587 | 18.703 | 16.075 |
| Earnings Per Share | -107.882 | -103.249 | -1.238 | 6.049 | 2.725 | -3.148 |
| Cash Per Share | 118.215 | 77.307 | 9.597 | 23.925 | 8.03 | 7.019 |
| Working Capital Per Share | 100.312 | 50.117 | 9.261 | 16.088 | 16.531 | 14.27 |
| Operating Profit Per Share | N/A | N/A | N/A | 9.721 | 7.546 | 0.352 |
| EBIT Per Share | -97.022 | -86.907 | -1.087 | 7.231 | 4.194 | -3.047 |
| EBITDA Per Share | -97.022 | -86.907 | -1.087 | 7.231 | 4.194 | -3.047 |
| Free Cash Flow Per Share | -109.382 | -102.821 | -1.244 | 6.065 | 2.729 | -3.09 |
| Fin d'année 31 Décembre 2023 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A |
| Actions en circulation | 186k | 257k | 35,05M | 35,47M | 35,47M | N/A |
| Fin d'année 31 Décembre 2023 | Déc 2022 | Mar 2023 | Juin 2023 | Sept 2023 | Déc 2023 | Mar 2024 | Juin 2024 | Sept 2024 |
|---|---|---|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |||
| Actions en circulation | 35,47M | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Margin (%) | N/A | -113.95 | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Profit Margin (%) | N/A | -123.47 | N/A | N/A | N/A | N/A | N/A | N/A |
| Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Current Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Quick Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Capitalisation boursière | 263,77M |
| Ratio cours/bénéfice | -2,4 |
| Ratio prix/ventes | 21,47 |
| Ratio prix/liquidités | 1,08 |
| Ratio prix/valeur comptable | 0,47 |
| Rendement de dividende | - |
| Actions en circulation | 36,53M |
| Volume moyen (1 semaine) | 460,8k |
| Volume moyen (1 mois) | 427,35k |
| Variation sur 52 semaines | -32,64% |
| Plus haut sur 52 semaines | 18,75 |
| Plus bas sur 52 semaines | 7,12 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
